475 / 521
2009 to their customers in Turkish Liras. (26.03.2014; 14-
12/222-98)
• The Board decided that an individual exemption shall be grant-
ed to the “Distribution Agreement” and the amendment text
signed between Tekeda İlaç Sağlık Sanayi ve Ticaret Ltd. Şti.
and Anika Therapeutics, Inc. (03.04.2014)
• The Board has found no objections to authorizing the transfer
of the operating rights of Dalaman Airport Domestic Terminal
and its Complementaries, as well as International Terminal and
its Complementaries, to YDA İnşaat Sanayi ve Ticaret A.Ş. for
25 years. (09.04.2014; 14-14/255-110)
• The Board has found no objections to authorizing the transfer
of the operating rights of Milas-Bodrum Airport Domestic
Terminal and its Complementaries, as well as International
Terminal and its Complementaries, to TAV Havalimanları
Holding A.Ş for 20 years. (09.04.2014; 14-14/256-111)
• The Board decided that the vertical relationship between
Altınbaş Petrol ve Ticaret A.Ş. and Yunak Otomotiv İnşaat ve
Sanayi Ticaret Ltd. Şti. shall benefit from the group exemption
within the scope of the Communiqué numbered 2002/2 until the
date of 20.09.2015. (16.04.2014; 14-15/271-115)
• The Board granted an individual exemption to the Sales
Agreement dated 01.06.2013 and signed between Chiesi İlaç
Ticaret A.Ş. and Özsel Ecza Depoları Tic. ve Paz. A.Ş., con-
cerning the products Curosurf and Aggrastat, on the condition
that the Peyona branded product was also included in the agree-
ment. (30.04.2014; 14-16/292-124)
• The Board decided that the Franchising Agreements to be con-
cluded between Brisa Bridgestone Sabancı Lastik Sanayi ve
Ticaret A.Ş. and OtoPratik/ProPratiktaları branches could ben-
efit from block exemption under the Communiqué No. 2005/4
except the non-compete obligation, which was granted an indi-
vidual exemption. Additionally, the agreements concluded with
Karat Güç Sistemleri San. ve Tic. A.Ş. were granted individual
exemptions for five years. (30.04.2014; 14-16/295-126)
LEGAL DEVELOPMENTS
459